Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study | Zendy

Mandeep R. Mehra | Zendy; Christopher T. Salerno | Zendy; Joseph C. Cleveland | Zendy; Sean Pinney | Zendy; M. Yuzefpolskaya | Zendy; Carmelo A. Milano | Zendy; Akinobu Itoh | Zendy; Daniel J. Goldstein | Zendy; Nir Uriel | Zendy; Sanjeev Gulati | Zendy; Francis D. Pagani | Zendy; Ranjit John | Zendy; Robert Adamson | Zendy; Roberta C. Bogaev | Zendy; Vinay Thohan | Zendy; Joyce Chuang | Zendy; Poornima Sood | Zendy; Scott Goates | Zendy; Scott Silvestry | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study

Author(s) -

Mandeep R. Mehra,

Christopher T. Salerno,

Joseph C. Cleveland,

Sean Pinney,

M. Yuzefpolskaya,

Carmelo A. Milano,

Akinobu Itoh,

Daniel J. Goldstein,

Nir Uriel,

Sanjeev Gulati,

Francis D. Pagani,

Ranjit John,

Robert Adamson,

Roberta C. Bogaev,

Vinay Thohan,

Joyce Chuang,

Poornima Sood,

Scott Goates,

Scott Silvestry

Publication year - 2018

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.118.035722

Subject(s) - medicine , destination therapy , randomized controlled trial , emergency medicine , censoring (clinical trials) , clinical trial , relative risk , transplantation , resource use , clinical endpoint , heart transplantation , surgery , confidence interval , pathology , natural resource economics , economics

The MOMENTUM 3 trial compares the centrifugal HeartMate 3 (HM3) with the axial HeartMate II (HMII) continuous-flow left ventricular assist system in patients with advanced heart failure, irrespective of the intended goal of therapy. The trial's 2-year clinical outcome (n=366) demonstrated superiority of the HM3 for the primary end point (survival free of a disabling stroke or reoperation to replace or remove a malfunctioning pump). This analysis evaluates health resource use and cost implications of the observed differences between the 2 devices while patients were enrolled in the trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research